Adirondack Trust Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
19,711
-350
| -2% | -$20.1K | 0.34% | 58 |
|
|
2026
Q1 | $1.22M | Sell |
20,061
-3,104
| -13% | -$181K | 0.41% | 50 |
|
|
2025
Q4 | $1.25M | Sell |
23,165
-203
| -0.9% | -$9.77K | 0.41% | 52 |
|
|
2025
Q3 | $1.05M | Sell |
23,368
-334
| -1% | -$15.6K | 0.35% | 59 |
|
|
2025
Q2 | $1.1M | Sell |
23,702
-1,890
| -7% | -$92.8K | 0.4% | 59 |
|
|
2025
Q1 | $1.56M | Sell |
25,592
-556
| -2% | -$32.4K | 0.61% | 41 |
|
|
2024
Q4 | $1.48M | Sell |
26,148
-779
| -3% | -$43.5K | 0.56% | 44 |
|
|
2024
Q3 | $1.39M | Sell |
26,927
-639
| -2% | -$30K | 0.54% | 46 |
|
|
2024
Q2 | $1.14M | Sell |
27,566
-314
| -1% | -$14.1K | 0.47% | 53 |
|
|
2024
Q1 | $1.51M | Sell |
27,880
-575
| -2% | -$29.3K | 0.63% | 40 |
|
|
2023
Q4 | $1.44M | Sell |
28,455
-1,047
| -4% | -$55K | 0.62% | 41 |
|
|
2023
Q3 | $1.71M | Sell |
29,502
-149
| -0.5% | -$9.13K | 0.85% | 29 |
|
|
2023
Q2 | $1.84M | Sell |
29,651
-1,509
| -5% | -$101K | 0.86% | 27 |
|
|
2023
Q1 | $2.16M | Sell |
31,160
-258
| -0.8% | -$18.2K | 1.09% | 24 |
|
|
2022
Q4 | $2.26M | Buy |
31,418
+117
| +0.4% | +$8.82K | 1.17% | 24 |
|
|
2022
Q3 | $2.23M | Buy |
31,301
+2
| +0% | +$145 | 1.24% | 21 |
|
|
2022
Q2 | $2.41M | Buy |
31,299
+763
| +2% | +$58.1K | 1.29% | 20 |
|
|
2022
Q1 | $2.23M | Buy |
30,536
+2,327
| +8% | +$156K | 1.06% | 24 |
|
|
2021
Q4 | $1.76M | Sell |
28,209
-660
| -2% | -$38.7K | 0.84% | 32 |
|
|
2021
Q3 | $1.69M | Buy |
28,869
+308
| +1% | +$20.3K | 0.8% | 32 |
|
|
2021
Q2 | $1.91M | Buy |
28,561
+320
| +1% | +$20.9K | 0.96% | 25 |
|
|
2021
Q1 | $1.78M | Buy |
28,241
+1,755
| +7% | +$109K | 0.95% | 23 |
|
|
2020
Q4 | $1.63M | Buy |
26,486
+120
| +0.5% | +$7.38K | 0.98% | 22 |
|
|
2020
Q3 | $1.59M | Buy |
26,366
+470
| +2% | +$28.3K | 1.04% | 23 |
|
|
2020
Q2 | $1.52M | Sell |
25,896
-330
| -1% | -$19.7K | 1% | 23 |
|
|
2020
Q1 | $1.46M | Buy |
26,226
+955
| +4% | +$58.4K | 1.19% | 22 |
|
|
2019
Q4 | $1.59M | Buy |
25,271
+781
| +3% | +$44.7K | 1.04% | 25 |
|
|
2019
Q3 | $1.24M | Sell |
24,490
-120
| -0.5% | -$5.64K | 0.87% | 30 |
|
|
2019
Q2 | $1.12M | Sell |
24,610
-65
| -0.3% | -$3.03K | 0.78% | 34 |
|
|
2019
Q1 | $1.15M | Sell |
24,675
-311
| -1% | -$15.5K | 0.79% | 34 |
|
|
2018
Q4 | $1.3M | Sell |
24,986
-75
| -0.3% | -$4.03K | 1.01% | 27 |
|
|
2018
Q3 | $1.56M | Sell |
25,061
-205
| -0.8% | -$12.2K | 1.05% | 25 |
|
|
2018
Q2 | $1.4M | Buy |
25,266
+250
| +1% | +$13.5K | 0.99% | 26 |
|
|
2018
Q1 | $1.3M | Buy |
25,016
+603
| +2% | +$38.8K | 0.93% | 31 |
|
|
2017
Q4 | $1.5M | Sell |
24,413
-520
| -2% | -$32.5K | 1.09% | 24 |
|
|
2017
Q3 | $1.59M | Sell |
24,933
-55
| -0.2% | -$3.21K | 1.25% | 23 |
|
|
2017
Q2 | $1.39M | Sell |
24,988
-5,336
| -18% | -$290K | 1.12% | 24 |
|
|
2017
Q1 | $1.65M | Sell |
30,324
-1,948
| -6% | -$107K | 1.15% | 23 |
|
|
2016
Q4 | $1.89M | Sell |
32,272
-255
| -0.8% | -$13.9K | 1.31% | 20 |
|
|
2016
Q3 | $1.75M | Buy |
32,527
+70
| +0.2% | +$4.5K | 1.26% | 18 |
|
|
2016
Q2 | $2.39M | Sell |
32,457
-195
| -0.6% | -$13.8K | 1.7% | 14 |
|
|
2016
Q1 | $2.09M | Sell |
32,652
-295
| -0.9% | -$18.6K | 1.55% | 16 |
|
|
2015
Q4 | $2.05M | Sell |
32,947
-106
| -0.3% | -$7K | 1.62% | 16 |
|
|
2015
Q3 | $1.96M | Sell |
33,053
-1,255
| -4% | -$79.6K | 1.58% | 16 |
|
|
2015
Q2 | $2.28M | Sell |
34,308
-755
| -2% | -$49.8K | 1.7% | 14 |
|
|
2015
Q1 | $2.26M | Buy |
35,063
+235
| +0.7% | +$14.7K | 1.69% | 13 |
|
|
2014
Q4 | $2.06M | Sell |
34,828
-535
| -2% | -$30.2K | 1.54% | 16 |
|
|
2014
Q3 | $1.81M | Buy |
35,363
+865
| +3% | +$43.2K | 1.37% | 19 |
|
|
2014
Q2 | $1.67M | Buy |
34,498
+215
| +0.6% | +$10.6K | 1.28% | 23 |
|
|
2014
Q1 | $1.78M | Sell |
34,283
-1,400
| -4% | -$74.5K | 1.42% | 17 |
|
|
2013
Q4 | $1.9M | Buy |
35,683
+130
| +0.4% | +$6.62K | 1.54% | 16 |
|
|
2013
Q3 | $1.65M | Sell |
35,553
-800
| -2% | -$35.1K | 1.45% | 18 |
|
|
2013
Q2 | $1.62M | Buy |
+36,353
| New | +$1.58M | 1.48% | 18 |
|
Other funds holding BMY
Adirondack Trust Company's BMY Position: Q2 2026 in Review
Adirondack Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $20.1K and leaving 19,711 shares worth $1.14M. The position accounts for 0.34% of the portfolio, ranked #58.
Adirondack Trust Company first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.41M in Q2 2022. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Adirondack Trust Company held 19,711 shares of Bristol-Myers Squibb worth $1.14M as of Q2 2026.
- Adirondack Trust Company sold 350 Bristol-Myers Squibb shares in Q2 2026, an estimated $20.1K.
- Bristol-Myers Squibb made up 0.34% of Adirondack Trust Company's portfolio in Q2 2026, its #58 holding.
- Adirondack Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Adirondack Trust Company's Bristol-Myers Squibb position peaked at $2.41M in Q2 2022.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.